Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Eudocia Q. Lee"'
Autor:
Wenya Linda Bi, Erik H. Knelson, Eudocia Q. Lee, Alexandra M Giantini Larsen, Luis Fandino, Hassan Y. Dawood, Ian F. Dunn, Saksham Gupta, Ayal A. Aizer, Timothy R. Smith
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
IntroductionBrain metastases are the most common brain tumors in adults, whose management remains nuanced. Improved understanding of risk factors for surgical complications and mortality may guide treatment decisions.MethodsA nationwide, multicenter
Publikováno v:
CancerReferences. 126(20)
Lung cancer and its associated treatments can cause various neurologic complications, including brain and leptomeningeal metastases, epidural spinal cord compression, cerebrovascular events, and treatment-related neurotoxicities. Lung cancer care has
Autor:
E. Antonio Chiocca, Mark D. Johnson, Eudocia Q. Lee, Brian M. Alexander, Patrick Y. Wen, Andrew D. Norden, David A. Reardon, Diana D. Shi, Alexandra J. Golby, Lakshmi Nayak, Nils D. Arvold, Ian F. Dunn, Ayal A. Aizer, Keith L. Ligon, Elizabeth B. Claus
Publikováno v:
Journal of Neuro-Oncology. 135:581-591
While salvage re-irradiation is often used for recurrent high-grade glioma (HGG), there have been few comparisons between various re-radiation dose/fractionation schedules or with bevacizumab alone. We analyzed patients with recurrent HGG who receive
Autor:
Samantha Hammond, Nils D. Arvold, Lakshmi Nayak, Camilo E. Fadul, Debra LaFrankie, Eric T. Wong, Patrick Y. Wen, David A. Reardon, Santosh Kesari, Alona Muzikansky, Julee Pulverenti, Eudocia Q. Lee, Lisa Doherty, Mikael L. Rinne, Jan Drappatz, Sandra Ruland, Sarah C. Gaffey, Katrina H. Smith, Brian M. Alexander, Jennifer Stefanik, Andrew D. Norden
Publikováno v:
Neuro-Oncology. 18:849-854
BACKGROUND: Fatigue is a common symptom among glioma patients and affects quality of life. Armodafinil, a wakefulness-promoting medication, benefits patients with fatigue of various causes. This study evaluates the effects of armodafinil on fatigue i
Autor:
L. Burt Nabors, Tracy T. Batchelor, Lisa M. DeAngelis, Susan M. Chang, Patrick Y. Wen, Manmeet Ahluwalia, Mary Jane Lim-Fat, David A. Reardon, Ugonma Chukwueke, Wenya Linda Bi, Minesh P. Mehta, Evanthia Galanis, Ingo K. Mellinghoff, Lakshmi Nayak, Howard Colman, Timothy F. Cloughesy, J Ricardo McFaline-Figueroa, John de Groot, Eudocia Q. Lee, Andrew B. Lassman, Mark R. Gilbert, Linda M. Liau, Janet Lo, Warren Mason, E. Antonio Chiocca
Publikováno v:
Neurosurgery
Autor:
Manjinder Singh Kandola, Mikael L. Rinne, Ossama Al-Mefty, Nils D. Arvold, Lakshmi Nayak, Patrick Y. Wen, Andrew D. Norden, Eudocia Q. Lee, David A. Reardon, Brian M. Alexander, Wenya Linda Bi, Ian F. Dunn, Ayal A. Aizer, Rameen Beroukhim
Publikováno v:
Cancer. 121:4376-4381
BACKGROUND The prognosis for patients with atypical and malignant meningioma is guarded; whether the extent of resection is associated with survival-based outcomes in this population remains poorly defined. This study investigated the association bet
Autor:
Marek Ancukiewicz, Eric T. Wong, Benjamin Purow, Andrew B. Lassman, Rakesh K. Jain, Andrew D. Norden, Brian M. Alexander, Christine McCluskey, David Schiff, Katrina H. Smith, Shakti Ramkissoon, Eudocia Q. Lee, Thomas Kaley, Stephanie E. Weiss, Patrick Y. Wen, Dan G. Duda, Jan Drappatz, Jason T. Huse, Alona Muzikansky, Tom Mikkelsen, Rameen Beroukhim, Keith L. Ligon, Tracy T. Batchelor, Mary Gerard
Publikováno v:
Clinical Cancer Research. 21:3610-3618
Purpose: Vandetanib, a tyrosine kinase inhibitor of KDR (VEGFR2), EGFR, and RET, may enhance sensitivity to chemotherapy and radiation. We conducted a randomized, noncomparative, phase II study of radiation (RT) and temozolomide with or without vande
Autor:
Rifaquat Rahman, Nils D. Arvold, Lakshmi Nayak, Alexandra J. Golby, Mark D. Johnson, Elizabeth B. Claus, Rameen Beroukhim, E. Antonio Chiocca, David A. Reardon, Andrew D. Norden, Ian F. Dunn, Eudocia Q. Lee, Paul J. Catalano, Patrick Y. Wen, Brian M. Alexander
Publikováno v:
Journal of Neuro-Oncology. 124:137-146
Despite a high symptom burden, little is known about the incidence or predictors of hospitalization among glioblastoma patients, including risks during chemoradiation (CRT). We studied 196 consecutive newly diagnosed glioblastoma patients treated at
Autor:
Shyam K. Tanguturi, Brian M. Alexander, Patrick Y. Wen, Laura W. Christianson, Nils D. Arvold, M.C. Horvath, Lakshmi Nayak, Elizabeth B. Claus, Alexandra J. Golby, Ian F. Dunn, Ayal A. Aizer, Keith L. Ligon, Eudocia Q. Lee, Mark D. Johnson, E. Antonio Chiocca, David A. Reardon
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 92:384-389
Older patients with newly diagnosed glioblastoma have poor outcomes, and optimal treatment is controversial. Hypofractionated radiation therapy (HRT) is frequently used but has not been compared to patients receiving standard fractionated radiation t